Exosomes as biomarkers and therapeutic measures for ischemic stroke.

Ischemic stroke (IS) is the leading cause of long-term disability in the world and characterized by high morbidity, recurrence, complications, and mortality. Due to the lack of early diagnostic indicators, limited therapeutic measures and inadequate prognostic indicators, the diagnosis and treatment of IS remains a particular challenge at present. It has recently been reported that exosomes (EXOs) play a significant role in the pathogenesis and treatment of IS. The purpose of this paper is to probe the role of EXOs in diagnostic biomarkers and therapeutic measures for IS and to provide innovative ideas for improving the prognosis of IS. Copyright © 2022 Elsevier B.V. All rights reserved.

Citation

Yun Shi, Ruirui Wang, Lei Wang, Qing Liu, Lan Han, Xianchun Duan, Yanchun Zhang, Aizong Shen, Daiyin Peng, Weidong Chen, Zhaojie Ji. Exosomes as biomarkers and therapeutic measures for ischemic stroke. European journal of pharmacology. 2023 Jan 15;939:175477

Mesh Tags

Substances

PMID: 36543286

search → result